日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
07/08/2024 | 烟台绿叶医药控股(集团)有限公司 | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | 李莉 | 1213(L) | 47,638,668(L) | 8.89 | ||
07/08/2024 | 刘殿波 | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Luye Pharma Group Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Nelumbo Investments Limited | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Luye Life Sciences Group Ltd | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Luye Pharma Hong Kong Limited | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Luye Pharma Holdings Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Shorea LBG | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | 山东绿叶制药有限公司 | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | Ginkgo (PTC) Limited | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
07/08/2024 | AsiaPharm Investments Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
12/04/2024 | 山东绿叶制药有限公司 | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Shorea LBG | 1701(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | 烟台绿叶医药控股(集团)有限公司 | 1701(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Pharma Holdings Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Life Sciences Group Ltd | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Ginkgo (PTC) Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Pharma Hong Kong Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Pharma Group Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Nelumbo Investments Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | 刘殿波 | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | AsiaPharm Investments Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
1 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 18/11/2024 17:59 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |